Windrik Lynch, MD
Anesthesiology · Tallahassee, FLNPI 1720345754
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Nevro Corp. accounts for 64.5% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2022 at $8,622 and has fallen 81.4% since, to $1,604 in 2025. Among anesthesiology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $79.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$11K
- Medtronic$2K
- Globus Medical$740
- Stryker$645
- Abbott$624
- Relievant Medsystems, Inc.$610
- plus $2K from 20 others
What the payments were for
- Speaking & faculty fees$6,24036%
- Travel & lodging$2,92217%
- Food & beverage$8,41448%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 81 | $11,345 |
| Medtronic(2 entities) | 26 | $1,791 |
| Globus Medical(2 entities) | 16 | $740 |
| Stryker | 4 | $645 |
| Abbott | 13 | $624 |
| Relievant Medsystems, Inc. | 8 | $610 |
| Boston Scientific | 16 | $483 |
| Collegium Pharmaceutical, Inc. | 20 | $339 |
| Cerapedics Inc. | 4 | $332 |
| Scilex Pharmaceuticals Inc. | 9 | $137 |
| Painteq LLC | 1 | $104 |
| 4web, Inc. | 1 | $66 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| Daiichi Sankyo Inc. | 3 | $46 |
| Vertex | 2 | $32 |
| Johnson & Johnson | 1 | $31 |
| Pfizer | 2 | $29 |
| Almatica Pharma LLC | 2 | $28 |
| Smith+Nephew | 1 | $23 |
| SPR Therapeutics, Inc | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $18 |
| Averitas Pharma Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Assertio Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$8,153
- Intracept$1,136
- Senza Spinal Cord Stimulation System$1,056
- SYNCHROMED$529
- Senza$523
- mild Device Kit$517
- INTELLIS$311
- INTELLIS ADAPTIVESTIM$250
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$241
- XLIF$141
- Proclaim Family of SCS IPGs$138
- KYPHON Balloon Kyphoplasty$135
- Vyrsa V1$133
- KYPHON EXPRESS II KYPHOPAK TRAY$128
- GENERAL PAIN MANAGEMENT$121
- OCTRODE$119
- PROCLAIM$115
- PAINTEQ$104
How this compares
$17,576 in reported general payments places this provider in the 95th percentile of 2,767 anesthesiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 3,307 | $109,787 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 2,081 | $87,803 |
| Xtampza ErOxycodone Myristate | 42 | $25,506 |
| Morphine Sulfate ErMorphine Sulfate | 349 | $9,491 |
| Nucynta ErTapentadol Hcl | 12 | $8,225 |
| Pregabalin | 229 | $5,717 |
| ZtlidoLidocaine | 12 | $5,006 |
| Oxycodone Hcl | 258 | $4,794 |
| Celecoxib | 87 | $3,515 |
| Gabapentin | 208 | $3,081 |
| Tizanidine Hcl | 132 | $2,377 |
| Hydromorphone Hcl | 84 | $2,116 |
| Fentanyl | 22 | $2,071 |
| Tramadol Hcl | 171 | $1,806 |
| Morphine Sulfate | 72 | $1,725 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er | $339 | $33,73154 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $137 | $5,00612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,767 anesthesiology providers in Florida.
Other anesthesiology in Tallahassee
- Robert LondonOrlando$402K
- Todd HorowitzDelray Beach$267K
- Darren WredeLargo$211K
- Ralf GebhardMiami$166K
- Adam BlombergHollywood$120K
- Andre BoezaartGainesville$119K
- Samantha NiekampMiami$82K
- Jackson WagonerGainesville$70K
- Sorin BrullJacksonville$66K
- Roman DudarykMiami$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.